Welcome! Defeating Merkel cell carcinoma begins here.
The critical first step is to find a Merkel cell carcinoma specialist.
It is critical that each case be reviewed by a multidisciplinary team, including surgical oncologists, radiation oncologists, medical oncologists, and dermatologists with significant experience in managing MCC, in order to develop a plan for the patient.
To find healthcare professionals experienced with Merkel cell carcinoma, start with our list of verified specialists.Find a Specialist
Make sure your primary care team is knowledgeable and takes action.
Merkel cell carcinoma is rare, and it's common for many medical professionals to be unsure of where to start. When a diagnosis occurs, it is imperative that your medical team is knowledgeable and able to carry out an MCC specialist's plan.
Our clinical team recommends that all healthcare providers follow the NCCN guidelines for MCC to bring them up to speed on MCC and how to care for MCC patients.Get the Guide
Consider joining a patient-based group
A diagnosis of Merkel cell carcinoma is a life-changing experience. Support from others—in the form of advice, recommendations for local healthcare providers, or sharing personal victories—can help ease the burden many MCC patients and their families feel.
We encourage you to make connections; it’s been proven to help.Get Support
The latest advancements in treatment
Merkel cell carcinoma from renal transplant recipients are mostly MCPyV-negative and are frequently associated with squamous cell carcinomas or precursors
This study from France analyzed 15 cases of MCC in which the patients had a history of kidney transplant and thus were taking immune suppressive drugs. The authors found that 10 out of 15 of these MCC tumors were not caused by the Merkel cell polyomavirus (MCPyV). Of the 10 virus-negative MCC tumors...
NCCN Clinical Practice Guidelines in Oncology for Merkel Cell Carcinoma
The annual update of the National Comprehensive Cancer Network guidelines for MCC has just been posted.
Differences in Merkel Cell Carcinoma Presentation and Outcomes Among Racial and Ethnic Groups
In this population-based study of nearly 10,000 US patients with MCC, the authors found that Black patients are less likely to develop MCC than those with less skin pigmentation (about 6% of MCC cases were in Black patients, who make up about 15% of the US population). Black patients presented more ...